Member Info for Pangolin

VERY interesting!

uinsionn,

I don't wanna be rude but all you said is to be found on the site of IMM. Or is common knowledge.

Only thing that is interesting, if true, is that about taking part of the last placing.

Never let your emotions take over! Exception...in love... :-)

Maybe it will all become clear in the future.

Where's that damned SPA?

paid 11.30

shares, not pounds. :-)

I bought my last ( again...) 25K. Now 250K.

"Bad news is coming im long here but having these thoughts ."

I'd sell then.

chesee, what do you think? Do we wanna be out of this in the weekend?

I say: NOOOOOOO

Unless the demand for shares is higher than the ii's selling.

Curious about what the sp will do after SPA accepted.

"I'm sure the LTHs here will remember that Immunomedics had epratuzumab, which failed its Phase 3 lupus trial in 2015. The Immunomedics share price tanked, collapsing to $2.05. UCB pulled out of the collaboration. Yesterday, just 5 years later, Immunomedics was bought by Gilead for $88 per share, a 44-bagger! I'm not saying that will happen here. What I am saying is "

Maybe UCB is eyeing IMM to make that good? Fact is that UCB is in a takeover mood since a year. They have the resources to do that. And seen the MC of IMM...
Be sure that they follow IMM.

Could have been if their first P3 trial succeeded. Now that it is for Avion I don't know.

But what has UREkA in petto for us? Who has a good sight on that?

"For the moment , Avion has'nt taken any financial risk ....
No upfront payment ..."

Avion was and is in the driving seat!

"Does the non-USA market sales potential justify the current MC of £32mn, even assuming the SPA is granted?"

If the sales are more or less as expected and with a royalty of 17% the MC will be substantial higher than today.

SPA IN :-)

Or SPAIN?

Let us first have the approved SPA. Thereafter we'll have time enough to discuss P3 etc.

In a way, not so bad that we don't know when the news will come. Surprise effect !

1509,

Seen that. Take 100mio instead of 170 and it's still impressive.